Akorn Desoximetasone Ointment 0.25% Tubes Recalled Due to Phase Separation
Akorn recalls 0.25% Desoximetasone Ointment tubes (15g and 60g) due to phase separation risk. Check NDC codes 61748-206-15 and 61748-206-60 for affected products.
Lower-risk recall
Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
Contact the company
What happened, in plain English
Akorn has recalled two sizes of Desoximetasone Ointment 0.25% tubes because they may separate into layers. This could cause uneven medication delivery and potential skin irritation if used. Read more at govinfonow.com/recall/42253-akorn-desoximetasone-ointment-0-25-tubes-recalled-due-to-phase.
Source Summary by GovInfoNow · govinfonow.com/recall/42253-akorn-desoximetasone-ointment-0-25-tubes-recalled-due-to-phase · Updated October 8, 2026 · FDA enforcement record: FDA #D-0152-2017
Cite this page
“Akorn Desoximetasone Ointment 0.25% Tubes Recalled Due to Phase Separation.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42253-akorn-desoximetasone-ointment-0-25-tubes-recalled-due-to-phase. Based on FDA recall #D-0152-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0152-2017%22&limit=1).
Why it’s dangerous
The ointment may separate into layers due to stability issues. This could lead to uneven medication distribution and potential skin irritation when applied.
Who’s affected
People using the recalled ointment tubes for skin conditions. Those with sensitive skin may experience irritation if the ointment separates.
How to tell if you have this one
Check for 15g or 60g tubes labeled Desoximetasone Ointment USP 0.25%. Look for NDC codes 61748-206-15 or 61748-206-60 on the packaging.
- Brand
Akorn- Category
Drug
What to do — step by step
Check Product Label
Look for NDC codes 61748-206-15 or 61748-206-60 on the tube packaging to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0152-2017 (November 14, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0152-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.